American International Group’s Neos Therapeutics, Inc NEOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-30,250
Closed -$79K 3192
2019
Q1
$79K Sell
30,250
-564
-2% -$1.32K ﹤0.01% 2724
2018
Q4
$51K Buy
30,814
+12,016
+64% +$33.7K ﹤0.01% 2884
2018
Q3
$91K Buy
18,798
+761
+4% +$4.32K ﹤0.01% 2890
2018
Q2
$113K Buy
18,037
+2,218
+14% +$16.5K ﹤0.01% 2716
2018
Q1
$131K Sell
15,819
-850
-5% -$8.12K ﹤0.01% 2513
2017
Q4
$170K Buy
16,669
+3,760
+29% +$36.1K ﹤0.01% 2415
2017
Q3
$118K Buy
12,909
+965
+8% +$7.33K ﹤0.01% 2574
2017
Q2
$87K Buy
11,944
+3,323
+39% +$25.1K ﹤0.01% 2811
2017
Q1
$62K Buy
8,621
+720
+9% +$4.47K ﹤0.01% 2774
2016
Q4
$46K Sell
7,901
-22
-0.3% -$149 ﹤0.01% 2875
2016
Q3
$52.1K Buy
7,923
+12
+0.2% +$95 ﹤0.01% 2888
2016
Q2
$73.4K Buy
7,911
+4,722
+148% +$45K ﹤0.01% 2807
2016
Q1
$34K Buy
+3,189
New +$33.6K ﹤0.01% 4080

Other funds holding NEOS

American International Group's NEOS Position: Q2 2019 in Review

American International Group sold out of Neos Therapeutics, Inc (NEOS) in Q2 2019, closing a stake of 30,250 shares — an estimated $79K sold.

American International Group first reported a position in NEOS in Q1 2016 and held it in 13 quarters. The position peaked at $170K in Q4 2017. 58 funds tracked by Wall St. Rank hold NEOS as of Q2 2019.

  • American International Group reported no remaining Neos Therapeutics, Inc position as of Q2 2019 after selling out during the quarter.
  • American International Group sold 30,250 Neos Therapeutics, Inc shares in Q2 2019, an estimated $79K.
  • American International Group first reported a position in Neos Therapeutics, Inc in Q1 2016 and held it in 13 quarters.
  • American International Group's Neos Therapeutics, Inc position peaked at $170K in Q4 2017.
  • 58 funds tracked by Wall St. Rank held Neos Therapeutics, Inc as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.